Proactive Investors - Run By Investors For Investors

Dyadic International Inc stock ticks up on partnership announcement

Dyadic International Inc (OTCQX:DYAI) CEO Mark Emalfarb sat down with Proactive Investors' Christine Corrado at the Bio Investor Forum in San Francisco.

Proactive previously interviewed Ping Rawson about the company at the MicroCap Conference in October. 

Dyadic International is a global biotechnology company focused on further improving and applying the proprietary C1 expression system to help drug developers and manufacturers bring biologic drugs to market faster, in greater volumes, at lower cost, and with new properties that will improve access and cost to patients and the healthcare system.

View full DYAI profile View Profile

Dyadic International Inc Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use